AKT1 and neoplasm: More importantly, in consistent with the in vitro data, Tan IIA treatment contributed to dose-dependent increase in the Tie2 and AKT activities, but a decrease in the MLC activity both in the ischemic gastrocnemius (Figures 6(c) and 6(e)) and tumor tissues (Figures 6(d) and 6(f)).